Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)
Incyte Corporation
Incyte Corporation
Actuate Therapeutics Inc.
OHSU Knight Cancer Institute
Icahn School of Medicine at Mount Sinai
Nektar Therapeutics
Pierre Fabre Medicament